BeSTRO (ASBL)

Active

VAT

BE 0425.705.482

Full name

Belgian SocieTy for Radiotherapy & Oncology

Address

Avenue De La Couronne 20

1050 Ixelles

Established

10-06-1983

Principal activity

Advertising agencies

Try for free

Crisis resilience of BeSTRO

Which companies are best armed against current economic trends and the energy crisis?

2020		2019
Profit/Loss	€29,432	18%	€24,915
Equity	€249,489	13%	€220,057
Gross margin	€36,957	14%	€32,362

Publications in the Belgian Official Journal for BeSTRO

Type	Date	Pdf	Subject
	22-09-2023		Resignations, Appointments (FR)
	22-09-2023		Resignations - Appointments (NL)
	18-10-2022		Articles of Association (Translation, Coordination, Other Modifications, …) (NL)
	18-10-2022		Articles of Association (Translation, Coordination, Other Modifications, …) (FR)
	10-03-2022		Resignations, Appointments (FR)

Sources

Frequently asked questions

What is the VAT number of Belgian SocieTy for Radiotherapy & Oncology?

The VAT number of Belgian SocieTy for Radiotherapy & Oncology is BE0425705482.

When was Belgian SocieTy for Radiotherapy & Oncology founded?

Belgian SocieTy for Radiotherapy & Oncology was founded on 10-06-1983.

What is the address of Belgian SocieTy for Radiotherapy & Oncology?

The current registered office of Belgian SocieTy for Radiotherapy & Oncology is located at Avenue De La Couronne 20, 1050 Ixelles.

When was the last time Belgian SocieTy for Radiotherapy & Oncology filed their annual financial statements?

The most recent financial statements of Belgian SocieTy for Radiotherapy & Oncology were filed on 29-06-2021. You can view them here.

How many employees does Belgian SocieTy for Radiotherapy & Oncology have?

There are currently no employees working at Belgian SocieTy for Radiotherapy & Oncology or no workforce information is available.

What is the annual turnover of Belgian SocieTy for Radiotherapy & Oncology?

At the time of its most recent financial statements, Belgian SocieTy for Radiotherapy & Oncology did not publish any turnover figures. Belgian SocieTy for Radiotherapy & Oncology reported a gross margin of €36,957.00.